Oncology Immunotherapy Market, Global Outlook and Forecast 2023-2028

Report ID: 1147756 | Published Date: Jan 2025 | No. of Page: 69 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Oncology Immunotherapy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Oncology Immunotherapy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Oncology Immunotherapy Overall Market Size
    2.1 Global Oncology Immunotherapy Market Size: 2021 VS 2028
    2.2 Global Oncology Immunotherapy Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Oncology Immunotherapy Players in Global Market
    3.2 Top Global Oncology Immunotherapy Companies Ranked by Revenue
    3.3 Global Oncology Immunotherapy Revenue by Companies
    3.4 Top 3 and Top 5 Oncology Immunotherapy Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Oncology Immunotherapy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Oncology Immunotherapy Players in Global Market
        3.6.1 List of Global Tier 1 Oncology Immunotherapy Companies
        3.6.2 List of Global Tier 2 and Tier 3 Oncology Immunotherapy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Oncology Immunotherapy Market Size Markets, 2021 & 2028
        4.1.2 Immune Checkpoint Inhibitors
        4.1.3 Cytokine-Based Immunotherapy
        4.1.4 Cancer Vaccines
        4.1.5 CAR-T Cell Therapy
        4.1.6 Other
    4.2 By Type - Global Oncology Immunotherapy Revenue & Forecasts
        4.2.1 By Type - Global Oncology Immunotherapy Revenue, 2017-2022
        4.2.2 By Type - Global Oncology Immunotherapy Revenue, 2023-2028
        4.2.3 By Type - Global Oncology Immunotherapy Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Oncology Immunotherapy Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Drugstores
        5.1.4 Others
    5.2 By Application - Global Oncology Immunotherapy Revenue & Forecasts
        5.2.1 By Application - Global Oncology Immunotherapy Revenue, 2017-2022
        5.2.2 By Application - Global Oncology Immunotherapy Revenue, 2023-2028
        5.2.3 By Application - Global Oncology Immunotherapy Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Oncology Immunotherapy Market Size, 2021 & 2028
    6.2 By Region - Global Oncology Immunotherapy Revenue & Forecasts
        6.2.1 By Region - Global Oncology Immunotherapy Revenue, 2017-2022
        6.2.2 By Region - Global Oncology Immunotherapy Revenue, 2023-2028
        6.2.3 By Region - Global Oncology Immunotherapy Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Oncology Immunotherapy Revenue, 2017-2028
        6.3.2 US Oncology Immunotherapy Market Size, 2017-2028
        6.3.3 Canada Oncology Immunotherapy Market Size, 2017-2028
        6.3.4 Mexico Oncology Immunotherapy Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Oncology Immunotherapy Revenue, 2017-2028
        6.4.2 Germany Oncology Immunotherapy Market Size, 2017-2028
        6.4.3 France Oncology Immunotherapy Market Size, 2017-2028
        6.4.4 U.K. Oncology Immunotherapy Market Size, 2017-2028
        6.4.5 Italy Oncology Immunotherapy Market Size, 2017-2028
        6.4.6 Russia Oncology Immunotherapy Market Size, 2017-2028
        6.4.7 Nordic Countries Oncology Immunotherapy Market Size, 2017-2028
        6.4.8 Benelux Oncology Immunotherapy Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Oncology Immunotherapy Revenue, 2017-2028
        6.5.2 China Oncology Immunotherapy Market Size, 2017-2028
        6.5.3 Japan Oncology Immunotherapy Market Size, 2017-2028
        6.5.4 South Korea Oncology Immunotherapy Market Size, 2017-2028
        6.5.5 Southeast Asia Oncology Immunotherapy Market Size, 2017-2028
        6.5.6 India Oncology Immunotherapy Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Oncology Immunotherapy Revenue, 2017-2028
        6.6.2 Brazil Oncology Immunotherapy Market Size, 2017-2028
        6.6.3 Argentina Oncology Immunotherapy Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Oncology Immunotherapy Revenue, 2017-2028
        6.7.2 Turkey Oncology Immunotherapy Market Size, 2017-2028
        6.7.3 Israel Oncology Immunotherapy Market Size, 2017-2028
        6.7.4 Saudi Arabia Oncology Immunotherapy Market Size, 2017-2028
        6.7.5 UAE Oncology Immunotherapy Market Size, 2017-2028
7 Players Profiles
    7.1 Bristol-Myers Squibb
        7.1.1 Bristol-Myers Squibb Corporate Summary
        7.1.2 Bristol-Myers Squibb Business Overview
        7.1.3 Bristol-Myers Squibb Oncology Immunotherapy Major Product Offerings
        7.1.4 Bristol-Myers Squibb Oncology Immunotherapy Revenue in Global Market (2017-2022)
        7.1.5 Bristol-Myers Squibb Key News
    7.2 Merck & Co
        7.2.1 Merck & Co Corporate Summary
        7.2.2 Merck & Co Business Overview
        7.2.3 Merck & Co Oncology Immunotherapy Major Product Offerings
        7.2.4 Merck & Co Oncology Immunotherapy Revenue in Global Market (2017-2022)
        7.2.5 Merck & Co Key News
    7.3 Roche AG
        7.3.1 Roche AG Corporate Summary
        7.3.2 Roche AG Business Overview
        7.3.3 Roche AG Oncology Immunotherapy Major Product Offerings
        7.3.4 Roche AG Oncology Immunotherapy Revenue in Global Market (2017-2022)
        7.3.5 Roche AG Key News
    7.4 AstraZeneca
        7.4.1 AstraZeneca Corporate Summary
        7.4.2 AstraZeneca Business Overview
        7.4.3 AstraZeneca Oncology Immunotherapy Major Product Offerings
        7.4.4 AstraZeneca Oncology Immunotherapy Revenue in Global Market (2017-2022)
        7.4.5 AstraZeneca Key News
    7.5 Sanofi S.A.
        7.5.1 Sanofi S.A. Corporate Summary
        7.5.2 Sanofi S.A. Business Overview
        7.5.3 Sanofi S.A. Oncology Immunotherapy Major Product Offerings
        7.5.4 Sanofi S.A. Oncology Immunotherapy Revenue in Global Market (2017-2022)
        7.5.5 Sanofi S.A. Key News
    7.6 Dendreon Pharmaceuticals
        7.6.1 Dendreon Pharmaceuticals Corporate Summary
        7.6.2 Dendreon Pharmaceuticals Business Overview
        7.6.3 Dendreon Pharmaceuticals Oncology Immunotherapy Major Product Offerings
        7.6.4 Dendreon Pharmaceuticals Oncology Immunotherapy Revenue in Global Market (2017-2022)
        7.6.5 Dendreon Pharmaceuticals Key News
    7.7 Novartis
        7.7.1 Novartis Corporate Summary
        7.7.2 Novartis Business Overview
        7.7.3 Novartis Oncology Immunotherapy Major Product Offerings
        7.7.4 Novartis Oncology Immunotherapy Revenue in Global Market (2017-2022)
        7.7.5 Novartis Key News
    7.8 Gilead Sciences Inc.
        7.8.1 Gilead Sciences Inc. Corporate Summary
        7.8.2 Gilead Sciences Inc. Business Overview
        7.8.3 Gilead Sciences Inc. Oncology Immunotherapy Major Product Offerings
        7.8.4 Gilead Sciences Inc. Oncology Immunotherapy Revenue in Global Market (2017-2022)
        7.8.5 Gilead Sciences Inc. Key News
    7.9 Merck KGaA
        7.9.1 Merck KGaA Corporate Summary
        7.9.2 Merck KGaA Business Overview
        7.9.3 Merck KGaA Oncology Immunotherapy Major Product Offerings
        7.9.4 Merck KGaA Oncology Immunotherapy Revenue in Global Market (2017-2022)
        7.9.5 Merck KGaA Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Oncology Immunotherapy Market Opportunities & Trends in Global Market
    Table 2. Oncology Immunotherapy Market Drivers in Global Market
    Table 3. Oncology Immunotherapy Market Restraints in Global Market
    Table 4. Key Players of Oncology Immunotherapy in Global Market
    Table 5. Top Oncology Immunotherapy Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Oncology Immunotherapy Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Oncology Immunotherapy Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Oncology Immunotherapy Product Type
    Table 9. List of Global Tier 1 Oncology Immunotherapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Oncology Immunotherapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Oncology Immunotherapy Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Oncology Immunotherapy Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Oncology Immunotherapy Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Oncology Immunotherapy Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Oncology Immunotherapy Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Oncology Immunotherapy Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Oncology Immunotherapy Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Oncology Immunotherapy Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Oncology Immunotherapy Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Oncology Immunotherapy Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Oncology Immunotherapy Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Oncology Immunotherapy Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Oncology Immunotherapy Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Oncology Immunotherapy Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Oncology Immunotherapy Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Oncology Immunotherapy Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Oncology Immunotherapy Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Oncology Immunotherapy Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Oncology Immunotherapy Revenue, (US$, Mn), 2023-2028
    Table 30. Bristol-Myers Squibb Corporate Summary
    Table 31. Bristol-Myers Squibb Oncology Immunotherapy Product Offerings
    Table 32. Bristol-Myers Squibb Oncology Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 33. Merck & Co Corporate Summary
    Table 34. Merck & Co Oncology Immunotherapy Product Offerings
    Table 35. Merck & Co Oncology Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 36. Roche AG Corporate Summary
    Table 37. Roche AG Oncology Immunotherapy Product Offerings
    Table 38. Roche AG Oncology Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 39. AstraZeneca Corporate Summary
    Table 40. AstraZeneca Oncology Immunotherapy Product Offerings
    Table 41. AstraZeneca Oncology Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 42. Sanofi S.A. Corporate Summary
    Table 43. Sanofi S.A. Oncology Immunotherapy Product Offerings
    Table 44. Sanofi S.A. Oncology Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 45. Dendreon Pharmaceuticals Corporate Summary
    Table 46. Dendreon Pharmaceuticals Oncology Immunotherapy Product Offerings
    Table 47. Dendreon Pharmaceuticals Oncology Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 48. Novartis Corporate Summary
    Table 49. Novartis Oncology Immunotherapy Product Offerings
    Table 50. Novartis Oncology Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 51. Gilead Sciences Inc. Corporate Summary
    Table 52. Gilead Sciences Inc. Oncology Immunotherapy Product Offerings
    Table 53. Gilead Sciences Inc. Oncology Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 54. Merck KGaA Corporate Summary
    Table 55. Merck KGaA Oncology Immunotherapy Product Offerings
    Table 56. Merck KGaA Oncology Immunotherapy Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Oncology Immunotherapy Segment by Type in 2021
    Figure 2. Oncology Immunotherapy Segment by Application in 2021
    Figure 3. Global Oncology Immunotherapy Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Oncology Immunotherapy Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Oncology Immunotherapy Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Oncology Immunotherapy Revenue in 2021
    Figure 8. By Type - Global Oncology Immunotherapy Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Oncology Immunotherapy Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Oncology Immunotherapy Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Oncology Immunotherapy Revenue Market Share, 2017-2028
    Figure 12. US Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Oncology Immunotherapy Revenue Market Share, 2017-2028
    Figure 16. Germany Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 17. France Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Oncology Immunotherapy Revenue Market Share, 2017-2028
    Figure 24. China Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 28. India Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Oncology Immunotherapy Revenue Market Share, 2017-2028
    Figure 30. Brazil Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Oncology Immunotherapy Revenue Market Share, 2017-2028
    Figure 33. Turkey Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Oncology Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 37. Bristol-Myers Squibb Oncology Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Merck & Co Oncology Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Roche AG Oncology Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. AstraZeneca Oncology Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Sanofi S.A. Oncology Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Dendreon Pharmaceuticals Oncology Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Novartis Oncology Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Gilead Sciences Inc. Oncology Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Merck KGaA Oncology Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
69
Frequently Asked Questions
Oncology Immunotherapy Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oncology Immunotherapy Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oncology Immunotherapy Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports